Status:
COMPLETED
COVID-19 Risk Stratification
Lead Sponsor:
Brigham and Women's Hospital
Conditions:
Coronavirus
Coronavirus Sars-Associated as Cause of Disease Classified Elsewhere
Eligibility:
All Genders
18+ years
Brief Summary
The investigators seek to derive and validate a clinically useful risk score for patients with Coronavirus Disease 2019 to aide clinicians in the safe discharge of patients.
Detailed Description
The investigators a-priori plan the following analysis: 1. Derivation and Retrospective Validation. * Select all adult patients with a positive reverse transcription polymerase chain reaction for...
Eligibility Criteria
Inclusion
- Positive reverse transcription polymerase chain reaction for severe acute respiratory syndrome coronavirus 2
- Age 18 and older
Exclusion
- None
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 26 2020
Estimated Enrollment :
1326 Patients enrolled
Trial Details
Trial ID
NCT04339387
Start Date
March 1 2020
End Date
April 26 2020
Last Update
November 30 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115